Hyloris announces submission of Maxigesic® IV packaging data requested by the US FDA

Additional extractable & leachable data generated by an accredited lab facility located in North AmericaResults analyzed and evaluated by toxicological expertsPotential regulatory approval for... | April 18, 2023

Related Keywords

United States ,Belgium ,America ,American ,Stijn Van Rompay ,Sven Watthy ,Jean Luc Vandebroek ,Hyloris Pharmaceuticals ,Investor Relations Communications ,Hikma Pharmaceuticals ,Hyloris Pharmaceuticals Sa Euronext Brussels ,Linkedin ,Food Drug Administration ,Euronext Brussels ,Drug Administration ,Complete Response Letter ,Van Rompay ,Chief Executive Officer ,Luc Vandebroek ,Investor Relations ,Persistent Opioid Use After Minor ,Major Surgical Procedures ,Hyloris Pharmaceuticals Sa Stock Exchange ,News ,Information ,Press Release ,Dditional ,Xtractable ,Teachable ,Data ,Enerated ,Y ,N ,Aaccredited ,Lab ,Facility ,Ocated ,North ,Mericaresults ,Aanalyzed ,End ,Revaluated ,Toxicological ,Xpertspotential ,Egulatory ,Pproval Hyl Be0974363955 ,